Age-related Macular Degeneration

被引:0
作者
Wang, Wei [1 ]
Dean, Douglas C. [1 ]
Kaplan, Henry J. [1 ]
机构
[1] Univ Louisville, Dept Ophthalmol, Louisville, KY 40202 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Age-related Macular Degeneration (AMD) is the major cause of vision loss after age 50 in the United States. Although an important association of the complement cascade with AMD has recently been made, we still do not understand the pathogenesis of the disease. AMD is characterized by loss of the retinal pigment epithelium (RPE) within the macula (i.e., the center of the retina), and in turn, loss of the overlying foveal photoreceptors. Since RPE and photoreceptors can both be generated from stem cells using cell culture, there is hope for future cell replacement therapy. But, aging changes in Bruch's membrane, the scaffold on which the RPE are anchored, may complicate such therapy, and require surgical repair of Bruch's membrane to provide a suitable environment for cell survival and function. We have referred to such a multipronged approach of surgical reconstruction of the macular architecture in conjunction with cell transplantation as Maculoplasty. [Discovery Medicine 9(44):13-15, January 2010]
引用
收藏
页码:13 / 15
页数:3
相关论文
共 15 条
[1]   Perspective - A role for local inflammation in the formation of drusen in the aging eye [J].
Anderson, DH ;
Mullins, RF ;
Hageman, GS ;
Johnson, LV .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (03) :411-431
[2]   GRANULOMATOUS REACTION TO BRUCHS MEMBRANE IN AGE-RELATED MACULAR DEGENERATION [J].
DASTGHEIB, K ;
GREEN, WR .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (06) :813-818
[3]   Complement factor H polymorphism and age-related macular degeneration [J].
Edwards, AO ;
Ritter, R ;
Abel, KJ ;
Manning, A ;
Panhuysen, C ;
Farrer, LA .
SCIENCE, 2005, 308 (5720) :421-424
[4]  
Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
[5]   Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration [J].
Gaudreault, J ;
Fei, D ;
Rusit, J ;
Suboc, P ;
Shiu, V .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (02) :726-733
[6]   Age-related macular degeneration - emerging pathogenetic and therapeutic concepts [J].
Gehrs, Karen M. ;
Anderson, Don H. ;
Johnson, Lincoln V. ;
Hageman, Gregory S. .
ANNALS OF MEDICINE, 2006, 38 (07) :450-471
[7]   Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration [J].
Gold, B ;
Merriam, JE ;
Zernant, J ;
Hancox, LS ;
Taiber, AJ ;
Gehrs, K ;
Cramer, K ;
Neel, J ;
Bergeron, J ;
Barile, GR ;
Smith, RT ;
Dean, M ;
Allikmets, R .
NATURE GENETICS, 2006, 38 (04) :458-462
[8]   Pegaptanib for neovascular age-related macular degeneration [J].
Gragoudas, ES ;
Adamis, AP ;
Cunningham, ET ;
Feinsod, M ;
Guyer, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816
[9]   Functional candidate genes in age-related macular degeneration:: Significant association with VEGF, VLDLR, and LRP6 [J].
Haines, JL ;
Schnetz-Boutaud, N ;
Schmidt, S ;
Scott, WK ;
Agarwal, A ;
Postel, EA ;
Olson, L ;
Kenealy, SJ ;
Hauser, M ;
Gilbert, JR ;
Pericak-Vance, MA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (01) :329-335
[10]   A TWIN STUDY OF AGE-RELATED MACULAR DEGENERATION [J].
MEYERS, SM ;
GREENE, T ;
GUTMAN, FA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 120 (06) :757-766